IRANIAN PRIMARY IMMUNODEFICIENCY REGISTRY (IPIDR)

Journal Title: Acta HealthMedica - Year 2017, Vol 2, Issue 6

Abstract

Introduction: Primary immunodeficiency diseases (PIDs) are a diverse group of genetic disorders which represent rare inborn errors of the immune system predisposing to recurrent infections, autoimmunity and malignancy. To achieve knowledge about the natural history of Iranian PIDs patients, we have established the central registry, entitled the Iranian Primary Immunodeficiency Registry (IPIDR). Methods: In order to determine the disease burden of all types of PIDs and collect the clinical and laboratory data of these patients, data has been recorded on the basis of a clinical data questionnaires since 1999, and continues to the present day. Results: In previous years, we published three reports of the Iranian Primary Immunodeficiency Registry (IPIDR). The first registry report was published in 2002 containing 440 PID patients, the second report was published in 2006 and included 930 patients (490 new cases), and third report was published in 2014 and consisted of 1,661(731 new cases) patients who registered during March 2006 through March 2013. By the last estimation in 2016, 2,021(360 new cases) patients were registered at the IPIDR. Notably, IPIDR has been nominated as a European Society for Immunodeficiencies (ESID) documenting center for registration of PID patients in Iran. Furthermore, Iranian Primary Immunodeficiency Network (IR PIN) (as a multidisciplinary organization dedicated to PID disorders) was established in 2016 to improve diagnosis of patients and collaboration between centers by the participation of all scientists and medical practitioners who are working on PIDs. Conclusion: This registry system is used as a tool to show the prevalence and characteristics of different PIDs phenotypes and can also help to better identify novel disease-associated genes and subsequently new diagnostic and therapeutic strategies for PID patients.

Authors and Affiliations

Fatemeh Kiaee, Naeimeh Tavakolinia, Reza Yazdani, Gholamreza Azizi, Hassan Abolhassani, Asghar Aghamohammadi

Keywords

Related Articles

DESIGN AND DEVELOPMENT OF THE COMPREHENSIVE TRAFFIC INJURY REGISTRY AS THE NATIONAL PILOT IN NORTH-WEST PROVINCES OF IRAN

Introduction: Many people think that putting data about traffic injuries into a computer or extracting traffic related data from a hospital information system could be called a traffic injury registry. No officially appr...

THE EFFECTS OF FEEDBACK-BASED INTERVENTION IN ERRORS DUE TO INAPPROPRIATE STORAGE AND TRANSPORTATION OF BLOOD BAGS IN HOSPITAL

Introduction: Storage and transportation of red blood cells (RBCs) outside the standard range temperature as defined by guidelines can lead to hemolysis. One of the main factors believed to cause hemolysis is temperature...

FREQUENCY OF CONGENITAL HYPOTHYROIDISM IN HORMOZGAN PROVINCE, IRAN

Background: Congenital hypothyroidism, defined as thyroid hormone deficiency at birth, is one of the most common preventable causes of mental retardation. Methods: This study was a cross sectional investigation conducte...

EVALUATION OF DEMOGRAPHIC CHARACTERISTICS AND FACTORS ASSOCIATED WITH POISONING IN CHILDREN ATTENDING THE KOODAKAN HOSPITAL OF BANDAR ABBAS

Background: Poisoning is a major public health problem and is still one of the most common causes of hospitalization and treatment of patients in emergency wards. Poisoning in children is also one of the most important c...

EAST AZERBAIJAN POPULATION BASED CANCER REGISTRY DURING 2015 TO 2016: PRELIMINARY REPORT

Introduction: The cancer registry programs provide reliable information on cancer data for evidence-based scientific cancer research. The National Pathology Cancer Registry Program started in 2001 in East Azerbaijan prov...

Download PDF file
  • EP ID EP351532
  • DOI 10.19082/ah162
  • Views 103
  • Downloads 0

How To Cite

Fatemeh Kiaee, Naeimeh Tavakolinia, Reza Yazdani, Gholamreza Azizi, Hassan Abolhassani, Asghar Aghamohammadi (2017). IRANIAN PRIMARY IMMUNODEFICIENCY REGISTRY (IPIDR). Acta HealthMedica, 2(6), 162-162. https://europub.co.uk/articles/-A-351532